Silo Pharma Inc.

OTCQB: SILO

Company Logo

Company Overview

Silo Pharma is a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research for people suffering from indications such as depression, PTSD, Parkinson’s, and other rare neurological disorders. Silo’s mission is to identify assets to license and fund the research which we believe will be transformative to the well-being of patients and the health care industry.

Financial Highlights

$59,096

Revenue (ttm)

$13,182

Gross Profit (ttm)

$0.00

Diluted EPS (ttm)

Management Team

Mr. Eric Weisblum
Chairman, Pres, Chief Compliance Officer, CEO & CFO

Sign Up for Alerts

Receive an email alert every time a company announces a merger, capital raise or files for an IPO.

Company Profile

Website

Twitter

Presentation

Key Highlights

Market Capitalization
$0

Shares Outstanding
0

Shares Short (% of Float)
0 (0%)

Insider Ownership
23%